← Leaderboards
Ryan Langlois
University Of Minnesota
$16,405,551
Attributed
$19,840,617
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $9.6M · FY2015–25$10M$7.5M$5M$2.5M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,840,617 · 8
By mechanism
R01$9,437,358 · 4
U19$8,451,808 · 1
R56$1,681,451 · 2
K22$270,000 · 1
Top collaborators
- David Masopust4 shared
- Zhongde Wang3 shared
- Siddharth Balachandran2 shared
- Carolina B. Lopez2 shared
Most similar at University Of Minnesota
Same institution · by research overlap
- Jakub Tolar$8,610,650
- Branden S Moriarity$9,306,595
- Douglas Yee$35,505,227
- Scott M. Dehm$10,389,676
- Robert J. Turesky$19,878,824
Others in their field
Top investigators on “Pathogen”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$343,790,695
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
- Jeffrey P Krischer · University Of South Florida$130,496,919
- Mark S Klempner · Tufts Medical Center$128,021,180
- Timothy Stedman · American Type Culture Collection$122,230,581
- Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai$99,962,183
Research focus
PathogenResponseCellsInfectionVirusLungImmune ResponseVirus ReplicationPreventIn VivoAntiviral ImmunityVirus DiseasesCell TypeVaccinesImmuneAnimalsEpithelial CellsInfluenza A VirusInterferonsPandemic DiseaseShapesImmunityComplexInfluenza
Grant awards (22)
Natural model for evaluating within- and cross-species virus transmission$702,509
R01 · FY2025 · AI · contact PI
Natural model for evaluating within- and cross-species virus transmission$725,409
R01 · FY2024 · AI · contact PI
New mouse model to better predict human immunity to influenza vaccination and infection$615,280
R01 · FY2024 · AI
Early Responses to Influenza A Virus Replication In Vivo$501,278
R01 · FY2024 · AI · contact PI
Harnessing ZBP1-triggered cell death to enhance influenza vaccine responsiveness$833,534
R56 · FY2023 · AI
Natural model for evaluating within- and cross-species virus transmission$739,159
R01 · FY2023 · AI · contact PI
New mouse model to better predict human immunity to influenza vaccination and infection$615,280
R01 · FY2023 · AI
Early Responses to Influenza A Virus Replication In Vivo$501,278
R01 · FY2023 · AI · contact PI
Core E: Cellular and Organismic Systems for Antiviral Testing$8,451,808
U19 · FY2022 · AI · contact PI
New mouse model to better predict human immunity to influenza vaccination and infection$615,280
R01 · FY2022 · AI
Early Responses to Influenza A Virus Replication In Vivo$501,278
R01 · FY2022 · AI · contact PI
Harnessing ZBP1-driven cell death to improve influenza vaccine efficacy$847,917
R56 · FY2021 · AI
New mouse model to better predict human immunity to influenza vaccination and infection$615,280
R01 · FY2021 · AI
Early Responses to Influenza A Virus Replication In Vivo$500,200
R01 · FY2021 · AI · contact PI
Mechanisms and consequences of epithelial cell survival from influenza virus infection.$385,000
R01 · FY2021 · AI · contact PI
Early Responses to Influenza A Virus Replication In Vivo$498,044
R01 · FY2020 · AI · contact PI
Mechanisms and consequences of epithelial cell survival from influenza virus infection.$385,000
R01 · FY2020 · AI · contact PI
Mechanisms and consequences of epithelial cell survival from influenza virus infection.$385,000
R01 · FY2019 · AI · contact PI
Mechanisms and consequences of epithelial cell survival from influenza virus infection.$769,791
R01 · FY2018 · AI · contact PI
Mechanisms and consequences of epithelial cell survival from influenza virus infection.$382,292
R01 · FY2017 · AI · contact PI
Harnessing microRNAs to explore influenza virus immunity$108,000
K22 · FY2016 · AI · contact PI
Harnessing microRNAs to explore influenza virus immunity$162,000
K22 · FY2015 · AI · contact PI